AbbVie Buy Hold or Sell Recommendation

ABBV -- USA Stock  

USD 86.04  1.93  2.19%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding AbbVie is 'Strong Hold'. Macroaxis provides AbbVie buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. The advice algorithm takes into account all of AbbVie available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from AbbVie buy-and-hold prospective. Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell AbbVieBuy AbbVie
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon AbbVie has a risk adjusted performance of 0.17, jensen alpha of 0.12, total risk alpha of 0.008609, sortino ratio of 0.0 and treynor ratio of 0.34
Macroaxis provides buy, hold, or sell suggestion on AbbVie to complement and cross-verify current analyst consensus on AbbVie. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure AbbVie is not overpriced, please confirm all AbbVie fundamentals including its Shares Outstanding, Net Income, Number of Employees, as well as the relationship between Price to Book and Book Value Per Share . Given that AbbVie has Price to Earning of 22.31 times, we suggest you validate AbbVie market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

AbbVie Thematic Classifications

Macroaxis Index IdeaMacroaxis Index
Macroaxis power theme of selected equities with solid fundamentals
Giant Impact IdeaGiant Impact
Public companies with mega capitalization

AbbVie Returns Distribution Density

Mean Return0.23Value At Risk2.51
Potential Upside1.89Standard Deviation1.44
 Return Density 

AbbVie Greeks

Alpha over DOW
Beta against DOW=0.69
Overall volatility
Information ratio =0.04

AbbVie Volatility Alert

AbbVie exhibits very low volatility with skewness of 0.08 and kurtosis of 0.06. However, we advise investors to further study AbbVie technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare AbbVie to competition

AbbVie Fundamental Vs Peers

FundamentalsAbbViePeer Average
Return On Equity489.67 % (15.17) %
Return On Asset11.00 % (15.64) %
Profit Margin20.84 % (5.50) %
Operating Margin41.86 % (10.91) %
Current Valuation173.73 B152.14 B
Shares Outstanding1.51 B1.43 B
Shares Owned by Insiders0.09 % 6.91 %
Shares Owned by Institutions71.54 % 18.37 %
Number of Shares Shorted31.01 M3.24 M
Price to Earning22.31 times40.69 times
Price to Book43.51 times14.44 times
Price to Sales4.40 times17.81 times
Revenue30.95 B9.85 B
Gross Profit21.53 B21.75 B
EBITDA12.95 B1.41 B
Net Income6.42 B517.71 M
Cash and Equivalents3.74 B3.89 B
Cash per Share2.47 times5.17 times
Total Debt37.75 B7.36 B
Current Ratio0.80 times3.30 times
Book Value Per Share2.23 times13.64 times
Cash Flow from Operations9.33 B1.25 B
Short Ratio6.26 times2.09 times
Earnings Per Share4.03 times2.30 times
Price to Earnings To Growth0.76 times1.22 times
Number of Employees30 K10.67 K
Market Capitalization136.13 B29.78 B
Total Asset53.05 B126.86 B
Retained Earnings4.38 B38.24 B
Working Capital5.42 B3.58 B
Current Asset16.31 B36.8 B
Current Liabilities10.89 B33.34 B
   Payment of 5901 shares by Azita SalekiGerhardt of AbbVie subject to Rule 16b-3 [view details]

AbbVie Alerts

Trading Alerts and Improvement Suggestions

AbbVie generates negative expected return over the last 30 days
The company currently holds 37.75 B in liabilities. AbbVie has Current Ratio of 0.78 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
About 72.0% of the company shares are held by institutions such as insurance companies
On October 12, 2018 AbbVie paid $ 0.96 per share dividend to its current shareholders
Latest headline from Acquisition by Robert Alpern of tradable shares of AbbVie subject to Rule 16b-3

Latest Analysts View

AbbVie Current Analysts Recommendations

Target Median Price105.50
Target Mean Price109.83
Recommendation Mean2.50
Target High Price157.00
Number Of Analyst Opinions18
Target Low Price78.00
Check also AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .